April 5, 2018 | 14 min. 36 sec. | Québec aujourd’hui (BLVD 102.1 FM)
Interview (in French) with Mathieu Bédard, Economist at the MEI, about the burdensome regulatory process delaying the reimbursement of new drugs by Canada’s public plans.
Link of interest: Innovative Drugs: A Bureaucratic Obstacle Course